News
4h
Zacks Investment Research on MSNModerna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspikeModerna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
They are getting a major change. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s ...
The FDA is planning a major shift in COVID-19 vaccine policy limiting future shots to seniors and high-risk groups while ...
13d
Zacks.com on MSNFDA’s New Requirements for COVID-19 VaccinesThough the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...
For many Americans, it's not clear how easy getting a COVID-19 vaccination this fall will be — or if they've lost the choice.
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
“By removing the recommendation, the decision could strip families of choice,” said O’Leary. “What is clear is that pregnant ...
The new framework unveiled May 20 says new COVID-19 shots should go only to those ages 65 and up or with underlying medical conditions.
The COVID-19 shot for healthy children and pregnant women has been removed from the Centers for Disease Control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results